|
UBA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.556100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.978200E-01 |
| Normal-vs-Stage2 |
7.893900E-02 |
| Normal-vs-Stage3 |
8.730000E-02 |
| Normal-vs-Stage4 |
2.837400E-01 |
| Stage1-vs-Stage2 |
1.688410E-01 |
| Stage1-vs-Stage3 |
1.348370E-01 |
| Stage1-vs-Stage4 |
5.016800E-01 |
| Stage2-vs-Stage3 |
4.974000E-01 |
| Stage2-vs-Stage4 |
6.243800E-01 |
| Stage3-vs-Stage4 |
3.007800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.433600E-02 |
| Normal-vs-AfricanAmerican |
1.805990E-01 |
| Normal-vs-Asian |
1.907390E-01 |
| Caucasian-vs-AfricanAmerican |
8.470600E-01 |
| Caucasian-vs-Asian |
2.819800E-01 |
| AfricanAmerican-vs-Asian |
2.718800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.541160E-01 |
| Normal-vs-Female |
1.442370E-03 |
| Male-vs-Female |
7.499800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.247820E-01 |
| Normal-vs-Extreme_Weight |
9.394200E-01 |
| Normal-vs-Obese |
3.922100E-02 |
| Normal-vs-Extreme_Obese |
5.487000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.141420E-01 |
| Normal_Weight-vs-Obese |
4.551200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.304800E-01 |
| Extreme_Weight-vs-Obese |
3.601500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.205800E-01 |
| Obese-vs-Extreme_Obese |
2.334600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.686300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.144300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.003200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.399600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.160100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.940300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.767570E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.147900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.321800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.098100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.183990E-01 |
| Normal-VS-Type2 PRCC |
3.917400E-01 |
| Normal-VS-KIRP CIMP |
5.356100E-02 |
| Normal-VS-Unclassified PRCC |
4.622500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.256600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.746400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.697410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.556300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.592600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.417600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.927600E-01 |
| Normal-vs-N1 |
4.941800E-02 |
| Normal-vs-N2 |
9.040200E-01 |
| N0-vs-N1 |
7.245500E-02 |
| N0-vs-N2 |
9.341200E-01 |
| N1-vs-N2 |
4.369200E-01 |
|
|
